NOVA Medical School strengthens data science research with the integration of Nuno Barbosa Morais

13-Feb-2026

NOVA Medical School announces the appointment of Nuno Barbosa Morais as associate professor and principal investigator of the Disease Transcriptomics laboratory.

Nuno Barbosa Morais is an experienced computational biologist, and holds a degree in Technologic Physics Engineering and a PhD in Biomedical Sciences. Throughout his career, he has built a scientific trajectory with a strong international dimension, having worked at leading institutions in the United Kingdom, Canada, and Portugal, and currently coordinating European excellence projects in the field of Biomedical Data Science.

His work has been recognized through highly competitive funding, including EMBO Installation Grants and an FCT Investigator Grant. More recently, he was awarded a Research Grant by the Portuguese League Against Cancer – Southern Regional Center.

At NOVA Medical School, the Disease Transcriptomics group will develop advanced computational approaches for large-scale genomic and transcriptomic data analysis, with the aim of deepening the understanding of the molecular mechanisms underlying pathologies such as cancer, neurodegenerative diseases, and other age-associated conditions. The research will seek to integrate molecular and clinical information to identify new biomarkers and potential therapeutic targets, reinforcing the institution’s mission to promote scientific excellence with an impact on health.

Nuno Barbosa Morais joins our faculty with the mission to strengthen the critical thinking component of biomedical data science training. He advocates for a sceptical and rigorous approach to big data analysis, promoting the use of computational tools as decision-support systems guided by sound scientific reasoning.

The appointment of Nuno Barbosa Morais represents a strategic reinforcement in the field of biomedical research and data science applied to health, contributing to consolidating NOVA Medical School’s position as a national and international reference in translational research.